Table 3.
Comparison of clinical baseline characteristics between APA-GI patients with HA and non-HA.
| Characteristic | non-HA | HA | P-value |
|---|---|---|---|
| Age(y), median(IQR) | 61.0 (50.0–70.5) | 63.0 (58.0–71.8) | 0.247 |
| Sex, Male/Female (Male%) | 22/19 (53.7) | 28/4 (87.5) | 0.002 |
| Primary site, n (%) | 0.321 | ||
| Stomach | 33 (80.5) | 27 (84.4) | |
| Large intestine | 7 (17.1) | 3 (9.4) | |
| Small intestine | 1 (2.4) | 0 (0.0) | |
| Esophagus | 0 (0.0) | 1 (3.1) | |
| Multiple primary sites | 0 (0.0) | 1 (3.1) | |
| Tumor size(cm), median(IQR) | 4.5 (3.5–5.3) | 5.0 (3.0–6.0) | 0.668 |
| Differentiation, n (%) | 0.007 | ||
| Highly differentiated | 0 (0.0) | 0 (0.0) | |
| Moderately differentiated | 17 (41.5) | 5 (15.6) | |
| Poorly differentiated | 21 (51.2) | 27 (84.4) | |
| Default | 3 (7.3) | 0 (0.0) | |
| pT, n (%) | 0.913 | ||
| 1 | 3 (7.3) | 2 (6.3) | |
| 2 | 6 (14.6) | 4 (12.5) | |
| 3 | 5 (12.2) | 6 (18.8) | |
| 4 | 27 (65.9) | 20 (62.5) | |
| pN, n (%) | 0.825 | ||
| 0 | 8 (19.5) | 7 (21.9) | |
| 1 | 6 (14.6) | 7 (21.9) | |
| 2-3 | 25 (61.0) | 17 (53.1) | |
| Default | 2 (4.9) | 1 (3.1) | |
| TNM staging, n (%) | 0.514 | ||
| I-III | 31 (75.6) | 22 (68.8) | |
| IV | 10 (24.4) | 10 (31.3) | |
| Liver metastasis | 0.084 | ||
| Yes | 9 (22.0) | 13 (40.6) | |
| No | 32 (78.0) | 19 (59.4) | |
| Extrahepatic metastasis | 0.756 | ||
| Yes | 22 (53.7) | 16 (50.0) | |
| No | 19 (46.3) | 16 (50.0) | |
| Lymphatic or/and blood vessel invasion | 0.269 | ||
| Yes | 19 (46.3) | 19 (59.4) | |
| No | 22 (53.7) | 13 (40.6) | |
| Nerve invasion | 0.486 | ||
| Yes | 11 (26.8) | 11 (34.4) | |
| No | 30 (73.2) | 21 (65.6) |
HA, hepatic adenocarcinoma; non-HA, non-hepatic adenocarcinoma.